Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-13

Clinical Trial Update: Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of X0002 for knee osteoarthritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • X0002

Snippet

Sponsor: Tianjin XinChen-Techfields Pharma Co., LTD. | Conditions: KNEE OSTEOARTHRITIS | Phase 2 | Status: COMPLETED